Description
LXH254 is a type II RAF inhibitor.
Product Unit Size | Cost | Quantity | Stock |
---|
LXH254 is a type II RAF inhibitor.
Cas No. | 1800398-38-2 |
---|---|
Purity | ≥99% |
Formula | C25H25F3N4O4 |
Formula Wt. | 502.49 |
IUPAC Name | N-[3-[2-(2-hydroxyethoxy)-6-morpholin-4-ylpyridin-4-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide |
Synonym | Naporafenib |
Appearance | White powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Monaco K, Delach S, Yuan J, et al. LXH254, a potent and selective ARAF-sparing inhibitor of BRAF and CRAF for the treatment of MAPK-driven tumors. Clin Cancer Res. 2021 Apr 1;27(7):2061-2073. PMID: 33355204
Park S, Kim T, Cho S, et al. Combined blockade of polo-like kinase and pan-RAF is effective against NRAS-mutant non-small cell lung cancer cells. Cancer Lett. 2020 Dec 28;495:135-144. PMID: 32979462
Potential ATP-sensitive K+ channel blocker, pot...
5-HT2/3/6/7, D2/3/4, histamine H1, α1-adrenerg...
Phenothiazine; D1/2 and α1-adrenergic antagoni...
Glycopeptide, binds D-Ala-D-Ala; cell wall synt...
Laminin-derived hexapeptide.
Wortmannin analog; PI3K inhibitor.
Synthetic peptide, fibrinogen derivative; glyco...
5-Nitroimidazole derivative; genotoxic.
COMT inhibitor.
Fibrate; PPARα agonist.
Iron chelator.
Camptothecin derivative; topoisomerase I inhibi...
Alkaloid found in Cephalotaxus; ribosomal prote...
γ-Secretase inhibitor.
FAAH inhibitor.
Sulfonamide; carbonic anhydrase inhibitor, volt...
Nucleoside (deoxyguanosine) analog; DNA chain t...
Xanthine derivative; adenosine antagonist, PDE ...
α1-adrenergic agonist.
Coumarin; VKORC1 inhibitor.